Systematic review of 17 studies (11 cost, 6 epidemiological) across Europe: estimated adult prevalence was 18% for obstructive sleep apnoea and 10% for insomnia; OSA (€184 billion) and insomnia (€158 billion) were the costliest sleep disorders.
Meta-analysisn = 17 studies
Bassetti et al. Epidemiology and Economic Burden of Sleep Disorders in Europe